Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

Insiders Menu
Roster
Transactions
Atea Pharmaceuticals, Inc. (AVIR)

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
11/14/2022BERGER FRANKLIN MDirectorSaleCommon Stock16.2k$5.16$83.4k 11/11/2022
11/11/2022BERGER FRANKLIN MDirectorSaleCommon Stock25.5k$5.15$131.3k 11/11/2022
06/17/2022BERGER FRANKLIN MDirectorGrantStock Option (Right to Buy)61.3k$6.50$398.2k 06/17/2022
06/17/2022Polsky BruceDirectorGrantStock Option (Right to Buy)61.3k$6.50$398.2k 06/17/2022
06/17/2022Duncan Barbara GayleDirectorGrantStock Option (Right to Buy)61.3k$6.50$398.2k 06/17/2022
06/17/2022Murphy Polly A.DirectorGrantStock Option (Right to Buy)61.3k$6.50$398.2k 06/17/2022
06/17/2022Lucidi BrunoDirectorGrantStock Option (Right to Buy)61.3k$6.50$398.2k 06/17/2022
06/17/2022Adams Jerome M.DirectorGrantStock Option (Right to Buy)61.3k$6.50$398.2k 06/17/2022
01/31/2022Horga Maria ArantxaChief Medical OfficerGrantStock Option (Right to Buy)170k$7.14$1.2M 01/31/2022
01/31/2022Vavricka JohnChief Commercial OfficerGrantStock Option (Right to Buy)135k$7.14$963.9k 01/31/2022
01/31/2022Hammond Janet MJChief Development OfficerGrantStock Option (Right to Buy)190k$7.14$1.4M 01/31/2022
01/31/2022Foster WayneEVP, Chief Accounting OfficerGrantStock Option (Right to Buy)120k$7.14$856.8k 01/31/2022
01/31/2022Sommadossi Jean-PierrePresident, CEO, and ChairmanGrantStock Option (Right to Buy)378k$7.14$2.7M 01/31/2022
01/31/2022Corcoran AndreaSee RemarksGrantStock Option (Right to Buy)181k$7.14$1.3M 01/31/2022
12/20/2021Murphy Polly A.DirectorPurchaseCommon Stock12k$8.57$102.8k 12/20/2021
06/18/2021Duncan Barbara GayleDirectorGrantStock Option (Right to Buy)34k$23.39$795.8k 06/18/2021
06/18/2021Murphy Polly A.DirectorGrantStock Option (Right to Buy)34k$23.39$795.8k 06/18/2021
06/18/2021Lucidi BrunoDirectorGrantStock Option (Right to Buy)34k$23.39$795.8k 06/18/2021
06/18/2021Polsky BruceDirectorGrantStock Option (Right to Buy)34k$23.39$795.8k 06/18/2021
06/18/2021BERGER FRANKLIN MDirectorGrantStock Option (Right to Buy)34k$23.39$795.8k 06/18/2021
05/18/2021Adams Jerome M.DirectorGrantStock Option (Right to Buy)56.7k$23.43$1.3M 05/18/2021
01/29/2021Horga Maria ArantxaChief Medical OfficerGrantStock Option (Right to Buy)145.5k$73.00$10.6M 01/29/2021
01/29/2021Vavricka JohnChief Commercial OfficerGrantStock Option (Right to Buy)117.3k$73.00$8.6M 01/29/2021
01/29/2021Sommadossi Jean-PierrePresident, CEO, and ChairmanGrantStock Option (Right to Buy)640k$73.00$46.7M 01/29/2021
01/29/2021Hammond Janet MJChief Development OfficerGrantStock Option (Right to Buy)160k$73.00$11.7M 01/29/2021
01/29/2021Corcoran AndreaSee RemarksGrantStock Option (Right to Buy)148.8k$73.00$10.9M 01/29/2021
01/29/2021Foster WayneEVP, Chief Accounting OfficerGrantStock Option (Right to Buy)71.8k$73.00$5.2M 01/29/2021
11/03/2020Murphy Polly A.DirectorConversionCommon Stock11.3k$0.00$0Held by the Marc & Polly Murphy Revocable Family Trust dated March 13, 200211/03/2020
11/03/2020Murphy Polly A.DirectorConversionSeries D Convertible Preferred Stock7.1k$0.00$0Held by the Marc & Polly Murphy Revocable Family Trust dated March 13, 200211/03/2020
11/03/2020Murphy Polly A.DirectorConversionSeries D-1 Convertible Preferred Stock4.2k$0.00$0Held by the Marc & Polly Murphy Revocable Family Trust dated March 13, 200211/03/2020
11/03/2020Corcoran AndreaSee RemarksConversionCommon Stock133k$0.00$0 11/03/2020
11/03/2020Corcoran AndreaSee RemarksConversionSeries A Convertible Preferred Stock100k$0.00$0 11/03/2020
11/03/2020Corcoran AndreaSee RemarksConversionSeries B Convertible Preferred Stock33k$0.00$0 11/03/2020
11/03/2020Hack Andrew A. F.DirectorPurchaseCommon Stock250k$24.00$6MSee Footnotes11/03/2020
11/03/2020Hack Andrew A. F.DirectorConversionSeries D Convertible Preferred Stock3.4M$0.00$0See Footnotes11/03/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy